Markets /GIKLY Grifols, S.A. GIKLY Full chart Compare Add to watchlist Set alert Price alert · GIKLY Alert when the price is Price abovePrice below Price level Set alert All alert types 5.55 USD 0.00 (+0.00%) At close·Nov 3, 2026, 4:00 PM EST Day range unavailable 5.06 52-week range 6.85 YTD -9.90%1 year -18.98% Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly Revenue by Segment FY 2025FY 2024FY 2023FY 2022 Haemoderivatives → Revenue: $6.49BRevenue → Gross Profit: $2.86BGross Profit → Net Income: $386.03MGross Profit → Selling, General & Admin: $1.06BGross Profit → Research & Development: $409.20MRevenue → Cost of Revenue: $4.67BGross Profit → Other Operating Expenses: $135.80MGross Profit → Interest Expense: $600.33MGross Profit → Other Expenses: $154.18MGross Profit → Income Tax: $110.46MTransfusional medicine → Revenue: $623.00MOther Product → Revenue: $243.00MBio supplies → Revenue: $154.00MOther diagnostic → Revenue: $17.00MGross Profit$2.86BCost of Revenue$4.67BNet Income$386.03MSelling, General & Admin$1.06BResearch & Development$409.20MOther Operating Expenses$135.80MInterest Expense$600.33MOther Expenses$154.18MIncome Tax$110.46MRevenue$7.52BHaemoderivatives$6.49BTransfusional medicine$623.00MOther Product$243.00MBio supplies$154.00MOther diagnostic$17.00M No annual statement lines GIKLY has no annual lines for this statement.
